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Introduction
Poly(ADP-ribosyl)ation is a post-translational modification of proteins operated by poly(ADP-ribose) polymerases (PARPs). These are nuclear and cytoplasmic enzymes metabolizing β-nicotinamide adenin dinucleotide (NAD + ) into polymers of ADP-ribose (Smith, 2001) , which, once targeted to proteins, serve as key regulators of their functions (D'Amours et al., 1999) . The majority of poly(ADPribose) (PAR) formation is due to the activity of nuclear PARP-1, a DNA damage-dependent enzyme with active roles in cell death (Pieper et al., 1999; Herceg and Wang, 2001; Yu et al., 2003) . Mounting evidence, however, indicates that PAR is synthesized also in the absence of DNA damage (Kun et al., 2002) , playing key roles in the homeostatic regulation of chromatin functions (de Murcia et al., 1988; D'Amours et al., 1999; Zlatanova et al., 2000) . For example, PARP-1 and PAR assist chromatin decondensation (de Murcia et al., 1988; Tulin and Spradling, 2003) , and regulate activity of transcription factors such as NF-κB, AP-1, AP-2, YY-1, Oct-1, p53, and HSF-1 (Chiarugi, 2002b; Ha et al., 2002; Hassa and Hottiger, 2002; Kraus and Lis, 2003; Zingarelli et al., 2003b; Ziegler and Oei, (Bonicalzi et al., 2003) . Little is known, however, about the role of PARG in cell homeostasis, albeit experimental evidence indicates the enzyme involved in development (Hanai et al., 2004) , differentiation (Di Meglio et al., 2003) , and cell death Ying et al., 2001) . These findings, along with the apparent cell cycle-dependent nuclear localization of PARG (Ohashi et al., 2003) , suggest an important role for this latter in the control of cell functioning.
Given the importance of PARG in PAR metabolism, and considering the relevance of PAR to transcription and immune activation, the present study investigated the effect of PARG inhibition on expression of pro-inflammatory mediators in macrophages.
Materials and Methods

Cells and culture conditions
Macrophages of the murine RAW 264.7 cell line were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 2mM glutamine, 10% bovine serum and antibiotics. Cultures were incubated at 37°C in a water-saturated 5% CO 2 / 95% air atmosphere and usually brought to 50-70%
confluence. Gallotannin (GLTN) (Fluka Chemie, CH) and the other drugs were directly dissolved in the incubating medium.
Western Blotting
For Western blotting, cells were scraped, collected in eppendorf tubes, centrifuged (1500 g/5 min/4°C) and resuspended in lysis buffer [50 mM Tris pH 7.4, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride (PMSF), 4 µg/ml aprotinin and leupeptin, 1% SDS]. 20-40 µg of protein/lane were loaded. After 4-20% SDS-PAGE and blotting, membranes (Hybond-ECL, Amersham, UK) were blocked with phosphate buffered saline (PBS) containing 0.1% Tween-20 and 5% skimmed milk (TPBS/5% milk) and then probed overnight with primary antibodies (1:1000 in TPBS/5% milk). The anti-PAR monoclonal antibody (10H) was from Alexis (Vinci, Italy), the anti-inducible NO synthase (iNOS), antiThis article has not been copyedited and formatted. The final version may differ from this version. interferon regulatory factor-1 (IRF-1), anti-interleukin (IL)-1β, anti tumor necrosis factor (TNF)-α were polyclonal antibodies from Santa Cruz Biotechnology (Santa Cruz, CA, USA), the anti-cyclooxygenase-2 (COX-2) polyclonal antibody was from Cayman Chemicals (Ann Arbor, MI, USA), the anti p38 and phospho-p38 were polyclonal antibody from BD Transduction Laboratories (Lexington, KY, USA), whereas the polyclonal anti phospho STAT-1 antibody was from Cell Signaling (Beverly, MA, USA).
Membranes were then washed with TPBS and incubated 1 h in TPBS/5% milk containing the corresponding peroxidase-conjugated secondary antibody (1:2000). After washing in TPBS, ECL (Amersham, UK) was used to visualize the peroxidase-coated bands.
Electrophoretic mobility shift assay
The DNA binding activity of NF-κB and AP1 was investigated in cells scraped, pelleted and then resuspended in buffer "A" containing 10 mM Hepes pH 7.8, 10 mM KCl, 1 mM EDTA, 0.1 mM EGTA, 1mM PMSF and 4 µg/ml aprotinin and leupeptin. Cells were kept on ice for 15 min, vortexed every 3 min and then centrifuged (5000 g/5 min/4°C). The nuclear pellet was resuspended in 50 µl of buffer "B", analogous to "A" plus 400 mM NaCl and incubated for 10 min on ice. The mixture was centrifuged (14,000 g/10 min/4°C) and the surnatant aliquoted and stored at -80°C. The DNA binding activity was tested by incubating 10 µg of proteins of the nuclear extract in 20 µl of a buffer containing 10 mM Tris pH 7.4, 4% glycerol, 1 mM MgCl 2 , 0.5 mM EDTA, 1 mM dithiothreitol, 50 mM NaCl, 0.05 mg/ml poly(dIdC), and 10,000 cpm of specific 32 P-labeled oligonucleotide for 20 min at room temperature. The mixture was electrophoresed in 6% non-denaturing polyacrylamide gels that, after drying, were exposed to x-ray films (Amersham, Little Chalfont Buckinghamshire, UK). The double-stranded oligonucleotides 5'-AGTTGAGGGGACTTTCCCAGGC-3' (NF-κB) and 5'-CGCTTGATGAGTCAGCCGGAA-3' (AP1) were used. For supershift experiments, 2µl of the antibodies raised against p65/RelA or c-Jun (Santa Cruz, CA, USA) were added to the binding mixture during incubation.
This article has not been copyedited and formatted. The final version may differ from this version. PCR amplification products were separated on a 1.8% agarose gel.
NAD measurement
NAD + contents were quantified by means of an enzymatic cycling procedure according to Shah et al. (Shah et al., 1995) . Briefly, cells grown in a 48 well plate were killed with 50 µl HClO4 1N and then neutralized with an equal volume of KOH 1N. After the addition of 100 µl of bicine 100 mM pH 8, 50 µl of the cell extract was mixed with an equal volume of the bicine buffer containing 23 µl/ml ethanol, 0.17 mg/ml MTT, 0.57 mg/ml fenazine ethosulfate and 10 µg alcohol dehydrogenase. Mixture
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Biotinylated NAD immunocytochemistry
Cells were grown on coverslips up to 50% confluence, washed with PBS and then incubated with buffer containing 56 mM HEPES, 28 mM NaCl, 2 mM MgCl 2 , 0.01% digitonin and 20 µM biotinylated NAD (bio-NAD, Trevigen, Gaithesburg, MD, USA) (Bakondi et al., 2002) . GLTN (100 µM), benzamide (BZD, 1 mM) or hydrogen peroxide (1mM) were added to the incubation buffer. Reaction was stopped after 30'-60' by fixing cells in cold ethanol for 5'. Later on, cells were dried and exposed to trichloroacetic acid (10% w/v in water) for 10' and washed twice with PBS. Biotinylated PAR was revealed by means of the ABC kit (Vector Laboratories, Burlingame, CA, USA).
RNA decay assay
For mRNA decay assay, cells were stimulated with 0.3 µg/ml LPS for 2h, washed twice with PBS and exposed to 10 µg/ml actinomycin-D (Act-D) dissolved in culture medium (Korhonen et al., 2002) . GLTN was added to cultures 30' after Act-D exposure to avoid direct interaction between the two drugs. At different incubation times mRNA was extracted from cells for RT-PCR.
RNA interference
The sequence of the double-stranded small interfering RNA (siRNA) fragments used for PARG silencing was 5'-AACGCCACCTCGTTTGTTTTC-3' (QIAGEN, Milan, Italy). The sequence of negative control siRNA (non silencing) was 5'-UUCUCCGAACGUGUCACGU-3' (QIAGEN, Milan, Italy). RNA was dissolved in the accompanying buffer and then in the oligofectamine (Invitrogen, San Giuliano Milanese, Italy) containing medium w/o serum according to the manufacturer's instruction. Cells (50-70% confluence) were exposed to siRNA for 4 h at 37°C and then an amount of DMEM+serum was
This article has not been copyedited and formatted. The final version may differ from this version. added to bring the serum concentration to 10%. After 24 h, total RNA was extracted for RT-PCR, or GLTN was added to the incubation medium for 6 h for Western blotting.
Results
Effect of GLTN on PAR metabolism
We first investigated the effects of PARG inhibition on PAR contents in RAW 246.7
macrophages. Among PARG inhibitors (Zhang and Li, 2002) , hydrolyzable tannins are potent compounds with GLTN being the only cell-permeable, non toxic and commercially available one (Tsai et al., 1992; Ying et al., 2001) . This finding further supports the hypothesis that GLTN inhibited PARG in our experimental setting.
This article has not been copyedited and formatted. The final version may differ from this version. Indeed, PARG activity is necessary to preserve PARP-dependent NAD + consumption by preventing excessive auto-poly(ADP-ribosyl)ation of PARP-1 and ensuing inactivation (Ying et al., 2001) . The reduced ability of GLTN to inhibit NAD depletion compared to that of PHE and BZD ( Fig. 1C ) was conceivably due to the fact that direct inhibition of PARP-1 by PHE or BZD is more efficient than its indirect inhibition by GLTN.
Further evidence that inhibition of PARG by GLTN increased PAR in RAW macrophages came from data obtained with immunocytochemistry of bio-PAR, formed by PARPs using bio-NAD as substrate (Bakondi et al., 2002) . Bio-NAD incorporation under control conditions was weak and mainly occurred in the periphery of both nucleus and nucleolus. After exposure to GLTN, massive bio-NAD incorporation occurred in the nucleus ( Fig. 2A ) in a time dependent manner (not shown). Significant incorporation also occurred in the cytoplasm. These findings suggest that PARG hydrolyzes PAR synthesized by both nuclear and cytoplasmic PARPs. In digitonin-permeabilized macrophages, assessment of PAR content by Western-blotting revealed increases of polymer after GLTN exposure higher than that detected in non-permeabilized cells (compare Fig. 2B with 1A) . This is probably due to the facilitated entrance of GLTN by digitonin. Importantly, BZD prevented GLTN-induced PAR accumulation, indicating that it was dependent on PAR neo-synthesis. Similar increases in PAR contents were detected in cells exposed to hydrogen peroxide, a classical trigger of PARP-1 activation and automodification ( Fig. 2A) .
Effect of GLTN on expression of pro-inflammatory mediators
Because PAR promotes the inflammatory response (Szabo, 1998; Ha et al., 2002; Chiarugi, 2002a; Chiarugi and Moskowitz, 2003) and no reports are available on the effects of GLTN on immune cells under resting conditions, in this study we sought to investigate whether GLTN-dependent PAR accumulation altered the expression of pro-inflammatory mediators in resting macrophages.
Interestingly, when used at concentrations inhibiting PARG, GLTN induced expression of iNOS and COX-2 in RAW macrophages (Fig. 3A) . The drug, however, did not induce expression of IL-1β and This article has not been copyedited and formatted. The final version may differ from this version. TNF-α (not shown). Of note, iNOS and COX-2 expression by GLTN was almost completely reduced by inhibitors of poly(ADP-ribosyl)ation such as PHE and BZD (Fig. 3B ). This indicates that expression of pro-inflammatory mediators by GLTN was dependent on PAR neo-formation and subsequent accumulation due to PARG inhibition. This assumption is further corroborated by the finding that tannins structurally related to GLTN, but unable to affect PARG activity, such as gallic acid, ellagic acid and epicatechin gallate (Tsai et al., 1992) , did not induce iNOS and COX-2 expression (Fig. 3C ).
To further strengthen the causal link between PARG activity and expression of pro-inflammatory mediators by GLTN, we silenced PARG by means of siRNAs. Pilot experiments aimed at determining oligofectamine transfection efficiency by using fluorescein-labeled oligoRNAs (QIAGEN, Milan, Italy) showed that roughly 50% of cells were transfected after 4 h exposure (not shown). siRNA for PARG reduced the enzyme's transcripts after 24 h, whereas mRNAs of PARP-1 or β-actin were not affected (Fig. 4Aa) . Notably, a negative control siRNA (QIAGEN, Milan, Italy) did not change PARG transcript levels (Fig. 4Ab) . Together, these findings indicate specificity of silencing by PARG siRNA. Because of the lack of commercially available anti-PARG antibodies, we could not evaluate the effects of siRNA on PARG protein expression levels. Regardless, GLTN-induced expression of iNOS and COX-2 was decreased (43±16% iNOS and 30±12% COX-2) in cells in which PARG was silenced compared to oligofectamine-treated controls (Fig. 4B ). Of note, PARG silencing affected neither β-actin expression nor induction of iNOS and COX-2 by LPS (Fig. 4C) . This on the one hand indicates that GLTN induced expression of the two inflammatory mediators by interacting with PARG, and on the other that PARG downregulation did not impair protein expression in a non specific manner. Silencing of PARG per se did not induce expression of pro-inflammatory mediators (not shown).
Effect of GLTN on inflammatory signal transduction pathways
Polymixin B, a LPS-neutralizing antibiotic, suppressed LPS-but not GLTN-induced iNOS expression (Fig. 5Aa) , ruling out the possibility that GLTN was contaminated by endotoxin. Similarly, This article has not been copyedited and formatted. The final version may differ from this version. LPS but not GLTN activated p38 (Fig. 5Ab ), a kinase with key roles in expression of pro-inflammatory mediators. We also studied the effects of GLTN on activation of transcription factors classically involved in expression of iNOS and COX-2. In extracts of RAW macrophages exposed to LPS (1µg/ml/1h), the DNA binding activities of NF-κB or AP1 appeared as retarded bands that were reduced by the addition to the binding mixture of an antibody raised against p65/RelA (NF-κB) or c-Jun (AP1). The bands were also reduced by 50-fold molar excess of cold probe, thereby indicating specificity of binding ( Fig. 5Ba   and b) . Surprisingly, GLTN inhibited the constitutive binding of NF-κB to the oligoprobe in gel shift assays (Fig. 5Ba) . This is consistent with the ability of polyphenols to suppress NF-κB activation (Pan et al., 2000) . As for AP1, we found constitutive DNA binding activity in RAW macrophages which was not affected by GLTN exposure (Fig. 5Bb) . Finally, GLTN induced neither STAT-1 phosphorylation nor IRF-1 expression, two events typically triggered by interferon-γ (Fig. 5C ).
Effect of GLTN on transcripts of pro-inflammatory mediators
We next analyzed mRNA levels of iNOS, COX-2, IL-1β and TNF-α in RAW cells exposed to GLTN. Consistent with data obtained with Western blotting, the drug increased the transcript levels of iNOS and COX-2 after 4 h exposure, but not those of TNF-α and IL-1β (Fig. 6Aa) . mRNA induction of iNOS and COX-2 by GLTN was slower than that triggered by LPS (2 h). The discrepancy between basal levels of TNF-α mRNA (Fig. 6A ) and lack of its constitutive expression (see above) is in keeping with the well known instability of TNF-α transcripts under resting conditions. Of note, Act-D abrogated GLTN-dependent increase of iNOS and COX-2 mRNA transcripts (Fig. 6Ab) , suggesting that expression of pro-inflammatory mediators prompted by GLTN, although apparently independent on activation of specific transcription factors, was still dependent on functioning of RNA polymerase II. To further rule out the possibility that GLTN increased iNOS and COX-2 transcript levels by mRNA stabilization, a mRNA decay assay was carried out. As shown in Fig. 6B , LPS-induced iNOS transcripts decreased after 5 h exposure to Act-D, whereas those of COX-2 and β-actin diminished only after 7 h.
This article has not been copyedited and formatted. The final version may differ from this version. The long half-life of COX-2 transcripts argues against the mRNA stabilizing properties of GLTN. Indeed, the drug did not affect iNOS or COX-2 transcript levels in cells challenged with LPS and exposed to Act-D (Fig. 6C ).
Discussion
This study shows that pharmacological inhibition of PARG leads to nuclear accumulation of PAR which in turn triggers expression of iNOS and COX-2 in cultured macrophages. To our knowledge, this is the first evidence that reduced catabolism of PAR alters inflammatory gene expression profile. Chiarugi and Moskowitz, 2003). In addition, poly(ADP-ribosyl)ation at specific promoter elements coordinates transcriptional activation (Butler and Ordahl, 1999; Nirodi et al., 2001; Akiyama et al., 2001; Soldatenkov et al., 2002) , and promotes expression of iNOS (Le Page et al., 1998) , chemokines (Nirodi et al., 2001; Hasko et al., 2002) , integrins (Ullrich et al., 2001 ), and muscle (Butler and Ordahl, 1999) as well as heat shock (Zingarelli et al., 2003a) proteins. In keeping with this scenario, our findings demonstrate that nuclear accumulation of PAR due to PARG inhibition triggers selective transcription of pro-inflammatory genes in macrophages. The apparent spontaneous (i.e.
activator independent) nature of GLTN-induced transcription is in line with a prior report showing that PAR promotes synthesis of mRNA (Vispè et al., 2000) . Data are also consistent with a recent study showing that PARG mutation selectively alters transcription of genes involved in circadian rhythm regulation in Arabidopsis. Remarkably, inhibition of PAR formation rescues the plant wild-type phenotype (Panda et al., 2002) .
After GLTN exposure, we have been unable to detect activation of signaling pathways typically triggered during iNOS and COX-2 induction in macrophages. However, it is worth noting that GLTN did This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 5) . Furthermore, under control conditions slight expression of iNOS and COX-2 was detected in some but not all experiments (compare blots in Fig. 3 ). We therefore hypothesize that PAR prompted a transcriptional machinery partially activated but unable per se to operate. That the drug acted through mechanisms different from those triggered by classical membrane receptor-dependent macrophage activators is also indicated by GLTN ability to induce, at variance with LPS, selective and delayed transcription of pro-inflammatory mediators (Fig. 6Aa) .
Although we cannot rule out the possibility that GLTN triggered cytoplasmic pathway(s) different from those investigated, our results, together with evidence that iNOS and COX-2 expression by GLTN was dependent on PAR formation (Fig. 3B ), point to PAR accumulation as the cause of transcription of the two pro-inflammatory mediators. Furthermore, the important finding that PARG silencing impaired GLTN's ability to induce expression of iNOS and COX-2 (Fig. 4B) corroborates the hypothesis that the drug acted via PARG inhibition, and emphasizes the enzyme's role in transcriptional regulation. In principle, this assumption is at odds with the finding that iNOS and COX-2 expression was not induced by the sole PARG silencing. However, PARG silencing by siRNA was partial (see Fig. 4Aa ), thereby allowing to speculate that remaining PARG activity warranted homeostatic levels of de-poly(ADPribosyl)ation (and PARG-dependent transcriptional repression). In addition, one should consider that acute inhibition of PARG by GLTN might have different impacts on both chromatin superstructure and transcription than a slow downregulation by siRNA. Finally, whereas siRNA only suppressed the known PARG isoform, it is conceivable that GLTN, as substrate analog, might have led to a more efficient suppression of de-poly(ADP-ribosyl)ation by inhibiting possible additional PARGs (Davidovich et al., 2001 ).
As for the molecular mechanisms through which inhibition of PARG promotes gene expression, it is worth noting that the enzyme has been shown to trigger chromatin condensation (de Murcia et al., 1986) , a hallmark of gene silencing, while accumulation of its substrate (i.e. PAR) leads to chromatin loosening (de Murcia et al., 1988; Tulin and Spradling, 2003) , a prerequisite of RNA polymerase IIThis article has not been copyedited and formatted. The final version may differ from this version. driven transcription. However, an alternative or complementary mechanism may also be advanced.
According to prior work from Satoh's group (Vispè et al., 2000) , DNA-damage dependent autopoly(ADP-ribosyl)ation of PARP-1 detaches the enzyme from nascent mRNA and relieves constitutive transcriptional blockade. Likewise, we report here that hindrance of PAR catabolism due to PARG inhibition is associated with PARP-1 auto-modification (Fig.1A, C and 2B ) and apparent, spontaneous transcriptional activation (Fig. 3A and 6Aa ). Taken together, data suggest that, when exceeding a certain threshold, PAR selectively unleashes mRNA elongation. It is therefore important to establish whether PARG similarly regulates transcription in other cell types. In this regard, preliminary results demonstrate that GLTN induced iNOS and COX-2 also in other mononuclear phagocyte cell lines such as NR 8383 (rat alveolar macrophages) and N11 (mouse microglia) (not shown). In human monocytederived macrophages, GLTN only induced COX-2 (not shown), in line with the well-known difficult induction of human iNOS in vitro.
In conclusion, the present study points to PARG as a novel player in epigenetics. Because PARG has a lower K m with respect to PARP-1 (Davidovich et al., 2001) , we reason that pharmacological modulation of the former rather than the latter should have a stronger impact on PARdependent transcription. In light of the role of PAR in the inflammatory response, PARG inhibition might boost immune cell activation and be exploited as an innovative immunomodulatory strategy. However, given the pleiotropic activities of pro-inflammatory transcription factors and cytokines, it is worth of mention that the PAR-dependent induction of iNOS and COX-2 without concomitant activation of NF-κB, AP1, STAT-1 or IRF-1 as well as IL-1β and TNF-α expression might have remarkable consequences on immunocompetence, survival and cytotoxicity of macrophages. As a whole, these findings might be of relevance to inflammation and have important pathophysiological implications that could be harnessed to therapeutic intervention.
